← Eichor
Study identifier: NCT06929663 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors

Condition: Advanced Solid Tumors  ·  Sponsor: Akeso

PhasePhase 1
Planned participants48
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is an first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK146D1 for injection in advanced solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Ting Liu  ·  +86(0760)8987 3999  ·  clinicaltrials@akesobio.com

Always discuss trial participation with your own doctor first.

Locations (1)

Scientia Clinical ResearchSydney, New South Wales, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06929663